These findings have therapeutic relevance, as combined high TNFSF4 and PECAM1 expression (as associated with OX40L-expressing blood vessels in tumors) is associated with better overall survival in NSCLC patients (HR = 0.68; Fig. 3E). Here, PECAM1 is linked to non-small cell lung carcinoma.